Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20687209rdf:typepubmed:Citationlld:pubmed
pubmed-article:20687209lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:20687209lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:20687209lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:20687209lifeskim:mentionsumls-concept:C1861733lld:lifeskim
pubmed-article:20687209lifeskim:mentionsumls-concept:C2674356lld:lifeskim
pubmed-article:20687209lifeskim:mentionsumls-concept:C2750816lld:lifeskim
pubmed-article:20687209lifeskim:mentionsumls-concept:C0002716lld:lifeskim
pubmed-article:20687209lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:20687209pubmed:issue3lld:pubmed
pubmed-article:20687209pubmed:dateCreated2010-9-6lld:pubmed
pubmed-article:20687209pubmed:abstractTextThe most widely studied positron emission tomography ligand for in vivo beta-amyloid imaging is (11)C-Pittsburgh compound B ((11)C-PIB). Its availability, however, is limited by the need for an on-site cyclotron. Validation of the (18)F-labeled PIB derivative (18)F-flutemetamol could significantly enhance access to this novel technology.lld:pubmed
pubmed-article:20687209pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20687209pubmed:languageenglld:pubmed
pubmed-article:20687209pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20687209pubmed:citationSubsetIMlld:pubmed
pubmed-article:20687209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20687209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20687209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20687209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20687209pubmed:statusMEDLINElld:pubmed
pubmed-article:20687209pubmed:monthSeplld:pubmed
pubmed-article:20687209pubmed:issn1531-8249lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:LinK ZKZlld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:BormansGuyGlld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:BrooksDavid...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:BuckleyChrisClld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:ThurfjellLenn...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:MinthonLennar...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:HasselbalchSt...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:SalmonEricElld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:BastinChristi...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:GarrauxGaëtan...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:VandenbergheR...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:IvanoiuAdrian...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:OweniusRikard...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:FarrarGillGlld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:AndersenAllan...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:NelissenNatal...lld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:TriauEricElld:pubmed
pubmed-article:20687209pubmed:authorpubmed-author:KornerAlexAlld:pubmed
pubmed-article:20687209pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20687209pubmed:volume68lld:pubmed
pubmed-article:20687209pubmed:ownerNLMlld:pubmed
pubmed-article:20687209pubmed:authorsCompleteYlld:pubmed
pubmed-article:20687209pubmed:pagination319-29lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:meshHeadingpubmed-meshheading:20687209...lld:pubmed
pubmed-article:20687209pubmed:year2010lld:pubmed
pubmed-article:20687209pubmed:articleTitle18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.lld:pubmed
pubmed-article:20687209pubmed:affiliationLaboratory for Cognitive Neurology, Catholic University Leuven, Leuven, Belgium. rik.vandenberghe@uz.kuleuven.ac.belld:pubmed
pubmed-article:20687209pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20687209pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20687209pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20687209lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20687209lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20687209lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20687209lld:pubmed